Key result
Hyodeoxycholic acid lowers the FXR-antagonist to agonist bile acid ratio ~85% in mice.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for hyodeoxycholic acid in lipid modulation; human studies required before any clinical consideration.
Mice were fed a control diet or a diet supplemented with hyodeoxycholic acid, the most abundant bile acid contained in pig bile, for 4 weeks, after which their serum and livers were collected. The contents of total fatty acids of serum and liver cholesteryl esters, and of liver triglycerides, were reduced following the administration of the hyodeoxycholic acid-supplemented diet, which was mainly due to the reductions in the contents of monounsaturated fatty acids. Free cholesterol contents in the serum and liver were not changed by hyodeoxycholic acid administration. Hyodeoxycholic acid administration reduced the gene expression levels of sterol regulatory element binding protein 1c, acetyl-CoA carboxylase, fatty acid synthase, and stearoyl-CoA desaturase-1. Hyodeoxycholic acid administration markedly changes the ratio of FXR-antagonist/FXR-agonist bile acids in the enterohepatic tissues of the mice (1.13 and 7.60 in hyodeoxycholic acid and control diet groups, respectively). Our findings demonstrate that hyodeoxycholic acid administration exerts the hypolipidemic effect in mice, in which downregulations of de novo lipogenesis and desaturation of saturated fatty acids are suggested to play important roles. In addition, regulation of FXR activation through the selective modification of the enterohepatic bile acid pool may be involved in the hypolipidemic effect of hyodeoxycholic acid administration.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (2014) studied Lipid and bile acid metabolism in mice. Hyodeoxycholic acid-supplemented diet vs. Control diet was evaluated on Ratio of FXR-antagonist/FXR-agonist bile acids in enterohepatic tissues and serum/liver lipid contents. Dietary hyodeoxycholic acid reduced serum/liver lipid contents and lowered the FXR-antagonist/FXR-agonist bile acid ratio vs control in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: